EGFR
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
EGFR
Jun 26, 2024, 12:40 |
Societies
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X: "Great summary from…
Jun 25, 2024, 13:50 |
Blog
Roy Herbst: Thrilled to host the lung interspore meeting
Roy Herbst, Chief of Medical Oncology at Yale University, shared a post on X: "Thrilled…
Jun 23, 2024, 10:44 |
Blog
IV vs Subcutaneous amivantamab in EGFR NSCLC
Eric K. Singhi shared a post by Stephen V Liu, on X: "Absolutely agree with this! Compared with…
Jun 22, 2024, 03:29 |
Insight
Triparna Sen: Celebrating 20 years of EGFR
Triparna Sen, Associate Professor at Icahn School of Medicine at Mount Sinai, posted on X: “Had…
Jun 21, 2024, 13:43 |
Insight
Luca Dezzani: We are requesting approval from the U.S. FDA EGFR-mutated NSCLC therapy
Luca Dezzani, Vice President of US Oncology Medical Affairs at Johnson & Johnson, shared a…
Jun 16, 2024, 12:44 |
Insight
Mara Antonoff: Dr Heather Wakelee clarifies the role of chemotherapy in NSCLC
Mara Antonoff, Associate Professor of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, shared on…
Jun 14, 2024, 03:39 |
Societies
Fred R. Hirsch: Great opening of Lung SPORE meeting
Fred R. Hirsch, Director at the Center for Thoracic Oncology at Mount Sinai Hospital, shared…
Jun 13, 2024, 15:48 |
Insight
Stephen Liu on a paper by Natasha Leighl, et al.
Stephen Liu recently shared a post on X: "PALOMA-3 results at Journal of Clinical Oncology…
Jun 10, 2024, 09:53 |
Blog
We are proud to be members of Lung Cancer Europe - Oncogene Cancer Research
Oncogene Cancer Research recently shared a post by Lung Cancer Europe on LinkedIn, adding: "We…
Jun 1, 2024, 21:10 |
Blog
LUNGevity Foundation - Subcutan injection or IV infusion for EGFR + NSCLC
LUNGevity Foundation shared a post on X: "Subcutan injection or IV infusion? Does it matter? Phas…
1
2
3
All:
30
Posts:
1 - 10
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
Facebook
RSS Feed
Twitter
Linkedin
Youtube